Gender Dysphoria Epidemiology Forecast 2025-2034

Gender Dysphoria Epidemiology Forecast Report Coverage

Expert Market Research's “Gender Dysphoria Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of gender dysphoria. It projects the future incidence and prevalence rates of gender dysphoria across various populations. The study covers age and type as major determinants of the gender dysphoria-affected population. The report highlights patterns in the prevalence of gender dysphoria over time and projects future trends based on multiple variables.

Gender Dysphoria: Disease Overview

Gender dysphoria, previously termed previously gender identity disorder, refers to the sense of unease that a person experiences due to an incongruence between an individual's biological sex and gender identity. Symptoms include feeling uncomfortable or distressed, disliking one's genitalia, and feeling isolated or lonely, among others. The condition can cause depression, anxiety, and other mental health disorders. Additionally, transgender people are likely to be at a higher risk for substance abuse and eating disorders.

Gender Dysphoria: Treatment Overview

Hormone therapy, behavioral health therapy, and surgery are the common treatment options for gender dysphoria. Hormone therapy helps suppress the natural hormones of the affected person and replaces them with cross-sex hormones. Surgery can also be opted to make such individuals comfortable in their gender identity. It includes breast, genital, facial, or vocal surgery, and is recommended to be performed after age 18. Behavioral health therapy is also useful for addressing mental health concerns or transition-related issues.

Epidemiology

The gender dysphoria epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for gender dysphoria by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for gender dysphoria and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• The prevalence of gender dysphoria is estimated to account for 0.005 to 0.014% of the population for people assigned male at birth and 0.002 to 0.003% for people assigned female at birth, as per the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition).
• According to a study published in General Psychiatry (2023), the estimated prevalence of gender dysphoria observed a rise between 2017 and 2021. Further, the average of diagnosis fell from 31 years in 2017 to 26 years in 2021.
• Men and women with gender dysphoria are reported to be more commonly affected by substance use disorders, with some studies indicating 28% of such individuals experiencing reported problems with substance abuse.
• Studies show that the gender dysphoria prevalence is higher in biological females in Japan and Poland.

Country-wise Gender Dysphoria Epidemiology

The gender dysphoria epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of gender dysphoria varies significantly between countries due to differences in cultural attitudes, social acceptance, healthcare access, and diagnostic practices, among others. In the United States, about 1.4 million people (0.6%) identify as transgender, as per a national survey.

Country Specific Stats:

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of gender dysphoria based on several factors.
• Gender Dysphoria Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of gender dysphoria are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of gender dysphoria epidemiology in the 8 major markets?
• What will be the total number of patients with gender dysphoria across the 8 major markets during the forecast period?
• What was the country-wise prevalence of gender dysphoria in the 8 major markets in the historical period?
• Which country will have the highest number of gender dysphoria patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of gender dysphoria during the forecast period of 2025-2034?
• What are the currently available treatments for gender dysphoria?
• What are the disease risks, signs, symptoms, and unmet needs of gender dysphoria?

Related Reports

Major Depressive Disorder Market

Anxiety and Depression Treatment Market